Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

Results from EHA23 indicate that belantamab mafodotin (belamaf) in combination with lenalidomide and dexamethasone holds great potential as a safe and effective option for patients with newly diagnosed multiple myeloma (MM) who are not suitable candidates for a transplant.